Both studies demonstrated that high expression of HIF-1α, p53 and cancer stems cell marker were significantly associated with tumor recurrence, poor treatment outcome, and poor overall survival in patients with HNSCC treated with RCHT. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.